Portfolio 4 Columns
The Chase Group Successfully Completes Search for Vice President, Research & Development at Alexza Pharmaceuticals
Alexza Pharmaceuticals stands at the crossroads of innovation...
The Chase Group Successfully Places David Geller, MD as Head of Pulmonary & Rare Disease Clinical Development for Arcturus Therapeutics
The Chase Group (TCG) is pleased to announce...
Drug Safety Leadership Team Grows at Ionis Pharmaceuticals Through Continued Partnership with The Chase Group
Ionis Pharmaceuticals retained The Chase Group to identify...
The Chase Group Continues Successful Collaboration with Genmab Through Placement of Vice President, CDTL
The Chase Group, known for its thorough search...
The Chase Group Successfully Secures Vice President, Head of Medical Development for Checkmate Pharmaceuticals
Building on a 14+ year relationship with Chase,...
Search Executed by The Chase Group, Inc. Results in Successful Appointment of Dr. Christophe Hotermans as SVP, Global Medical Affairs for Akcea Therapeutics
The Chase Group was once again retained by...
-
Appointment of William Andrews, M.D. as Chief Medical Officer at Akcea Therapeutics Successfully Completed by The Chase Group
The Chase Group, known for relationship building with...
Biologics Consulting Leadership Team Grows Through Partnership with The Chase Group
Through focused collaboration with The Chase Group, Biologics...
The Chase Group Secures New Leader for Informatics & Computational Biology at the Allen Institute for Immunology
Following an extensive search of industry and academic...
-
The Chase Group Successfully Completes the Appointment of Carla Poulson as Senior Vice President/Chief Human Resources Officer at Akcea Therapeutics
After a comprehensive executive search that was filled...
-
The Chase Group Secures Director of Drug Safety in Copenhagen/Denmark for Genmab
As a result of their partnership with The...
Partnership with The Chase Group Results in Successful Placement for Eisai Global Oncology Business Unit
The Chase Group is proud to partner with...
Aeglea Biotherapeutics Secures Another Executive for their Clinical Development Leadership Team
To support their rapid growth and expanding portfolio...
Eli Lilly Cyramza® Team Grows Through Continued Partnership with Chase
Utilizing their knowledge and years of experience recruiting...
-
A New Era Begins with Head of Pathology Placement at Genmab
Dr. Suzana Couto joins Genmab Pharmaceuticals as Head...
-
The Chase Group Makes Another Successful Placement at Eli Lilly
The Chase Group is pleased to continue our...
-
Aeglea BioTherapeutics Builds Rare Disease Clinical Development Team Through Partnership with The Chase Group, Inc.
Through our ongoing partnership, Aeglea Biotherapeutics has secured...
-
Eli Lilly Welcomes New Vice President, Immuno-Oncology Global & US Medical Affairs
The Chase Group is pleased to announce the...
The Chase Group Places VP of Clinical Development and Pharmacovigilance at Marinus Pharmaceuticals
The Chase Group is pleased to continue partnership...
-
The Chase Group Secures the Vice President, US and Global Medical Affairs for Eli Lilly
The Chase Group is pleased to announce the...
Ionis Pharmaceuticals Secures Associate Director, Investor Relations
The Chase Group is pleased to announce our...
-
The Chase Group Secures the Vice President, Global Head of Data Sciences for Genmab
The Chase Group is pleased to announce the...
-
A Successful Placement at Eisai, Inc.
The Chase Group is pleased to announce the...
-
Another Successful Placement by The Chase Group at Marinus Pharmaceuticals
The Chase Group is pleased to announce the...
Another Key Placement by The Chase Group
Dr. Eliel Bayever Joins OncoQuest as Chief Medical...
-
The Chase Group Successfully Completes Vice President, Clinical Development, Respiratory for Ionis Pharmaceuticals
The Chase Group appreciates and values our continued...
Corporate Communications Executive Secured for Ipsen Biopharmaceuticals
The Chase Group, Inc. is pleased to announce...
Esperion Therapeutics Taps The Chase Group to Fill Newly Created Role
Esperion Therapeutics has retained The Chase Group, Inc....
-
Vice President of Drug Safety for Ionis Pharmaceuticals Secured
The Chase Group announces another successful leadership recruitment...
-
Ionis Engages The Chase Group to Continue Building QA Team
Ionis Pharmaceuticals has retained The Chase Group, Inc....
-
Ipsen Retains The Chase Group for Senior Marketers
Ipsen Biopharmaceuticals has retained The Chase Group once...
-
Head of Regulatory Affairs Secured for Marinus
The Chase Group recently completed a highly competitive...
The Chase Group Secures VP of Information Technology for Isis Pharmaceuticals
The Chase Group is proud to announce the...
The Chase Group completes CMO search with Akcea Therapeutics
The Chase Group is proud to announce the...
AstraZeneca
AstraZeneca Oncology iSciences Retains The Chase Group for...
-
Eli Lilly
TCG completed another successful recruitment for Eli Lilly...
Entasis Therapeutics
The Chase Group proudly announces the successful completion...
-
Isis Pharmaceuticals
Dr. Roger Lane was successfully recruited by The...
Acorda Therapeutics
The Chase Group is actively recruiting for a...
RRD International
The Chase Group proudly announces the successful completion...
-
Esperion Therapeutics
The Chase Group is proud to announce the...
-
Ipsen Neurology
The Chase Group is proud to announce they...
-
Marinus Pharmaceuticals
The Chase Group is proud to announce the...
Abbvie
The Chase Group announces the recruitment of Toni...
-
Akcea Therapeutics
Akcea Therapeutics has retained The Chase Group to...